# REDHILL BIOPHARMA LTD (RDHL)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/RDHL/

- Reporting holders: 1
- Reported value: $138
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $138 | 287 | 0.0% | 8 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 1 | $138 |
| Q2 2026 | 15 | $325.3K |
| Q1 2026 | 15 | $386.5K |
| Q4 2025 | 16 | $514.5K |
| Q3 2025 | 13 | $51.2K |
| Q2 2025 | 11 | $37.9K |
| Q1 2025 | 11 | $80.5K |
| Q4 2024 | 10 | $103.5K |
| Q3 2024 | 9 | $48.8K |
| Q1 2023 | 1 | $77.0K |
| Q4 2022 | 2 | $2.4K |
| Q3 2022 | 2 | $39.0K |